Liver X receptor activation reduces gastric cancer cell proliferation by suppressing Wnt signalling via LXRβ relocalization
Open Access
- 19 October 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 23 (2) , 789-797
Abstract
Liver X receptors (LXRs) are involved in various diseases associated with lipid disorders, and in regulating cancer cell proliferation. However, the underlying molecular mechanisms, especially those in gastric cancer (GC) remain to be clarified. In this study, immunohistochemistry analysis revealed that LXRβ was mainly expressed in GC tissue, with less expression in adjacent normal tissues. The LXRβ agonist T0901317 efficiently suppressed the proliferation and colony formation of various GC cell lines. We further showed that LXRβ translocated from the cytoplasm to the nucleus when activated by T0901317. LXRβ nuclear localization suppressed the activation of Wnt signalling and decreased the expression of target genes such as MYC, BMP4, and MMP7 through binding to their promoters. Moreover, we demonstrated that the LXR agonist efficiently suppressed GC tumour growth in a nude mouse xenograft model. Taken together, these results revealed that LXRβ agonist inhibited GC cells proliferation by suppressing Wnt signalling via LXRβ relocalization. The results strongly suggest that LXRβ could be a promising target in GC therapy.Keywords
Funding Information
- National Natural Science Foundation of China (81502621, 81502088)
This publication has 23 references indexed in Scilit:
- Treatment of colon cancer with liver X receptor agonists induces immunogenic cell deathMolecular Carcinogenesis, 2018
- Liver X receptors as potential targets for cancer therapeutics (Review)Oncology Letters, 2017
- Targeting liver X receptors in cancer therapeuticsNature Reviews Cancer, 2015
- Liver X receptor β activation induces pyroptosis of human and murine colon cancer cellsCell Death & Differentiation, 2014
- The oxysterol receptors lxrα and lxrβ suppress proliferation in the colonMolecular Carcinogenesis, 2012
- Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cellsOncogene, 2010
- The oxysterol receptor LXR inhibits proliferation of human breast cancer cellsCarcinogenesis, 2009
- -Catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumoursHuman Molecular Genetics, 2008
- Myc deletion rescues Apc deficiency in the small intestineNature, 2007
- Wnt/β-Catenin Signaling in Development and DiseaseCell, 2006